Funding

#Cell and gene therapy #Funding #Microfluidics

€16.5m to advance automated, microfluidic CGT therapy 

Astraveus, providers of modular, microfluidic cell foundries for cell and gene therapy (CGT) manufacturing, has completed an oversubscribed €16.5 million Series Seed financing led by AdBio partners, co-syndicated with M Ventures, Johnson & Johnson Innovation – JJDC Inc., and Bpifrance Large Venture.  Astraveus’ Lakhesys platform is an end-to-end cell foundry… Read More

#Business & Investment #News

#Autolomous #Cell and gene therapy #Cell and Gene Therapy Catapult #Digitalisation #Funding

CGT grant funds implementation and digitisation of PAT  

Autolomous, a developer of critical manufacturing management systems for cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of CGTs, have been awarded a joint £1.2 million grant by UK Research and Innovation (UKRI),… Read More

#News

bone cancer
#Bone cancer #Childhood cancer #Funding #Osteosarcoma #Paediatrics

$1.5 million awarded for osteosarcoma research 

CureSearch for Children’s Cancer has awarded a $1.5 million grant to Dr Patrick Grohar of Children’s Hospital of Philadelphia to develop a new targeted treatment approach for paediatric osteosarcoma, an aggressive form of bone cancer.    The award – the Fight Osteosarcoma Together Super Grant – is a… Read More

#News

RNA strand
#Evotec #Funding #Immunology / Virology & Vaccines #Pandemic prevention #RNA #RNA sequencing

Grant supports discovery of RNA-targeting Henipavirus therapeutics

Evotec has received a $1.7 million grant from Open Philanthropy, a philanthropic funder prioritising global health and wellbeing. Under the grant, Evotec aims to discover and develop RNA-targeting small molecules as potential first-in-class therapeutics against Henipaviruses. Henipavirus is a genus of zoonotic viruses that… Read More

#News

#Funding #Investment #Private investment #Seed funding

DDW Highlights Podcast for 30 May 2023 now live

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The theme of DDW’s news review this week is money. Although Clarivate has reported a recent… Read More

#News

#Funding #Investment #Private investment #Seed funding

This week in drug discovery (22-26 May)

News round-up for 22-26 May by DDW Digital Content Editor Diana Spencer. The theme of our news review this week is money. Although Clarivate has reported a recent drop in investment in the industry, it is good to see companies raising money through funding rounds and… Read More

#News

#Artificial intelligence (AI) #Funding #Investment #Medicinal chemistry #Neurology #Oncology #PharmEnable

$7.5M investment to target cancer and neurological diseases

PharmEnable has closed a pre-series A investment round of $7.5 million to develop the next generation of small molecule drugs against disease areas of high clinical need. The funding round was led by MP Healthcare Venture Management (MPH), the venture arm of Mitsubishi Tanabe Pharma Group. There was also participation… Read More

#Business & Investment #News

Science connection and networking
#Biopharmaceuticals #BioTrinity #Comment #Events #Funding #Investment #Life sciences

Reflecting on BioTrinity 2023  

BioTrinity 2023 marked the 17th annual edition of BioTrinity and took place in London, UK from Tuesday 25 April to Wednesday 26 April. DDW’s Megan Thomas spoke with attendees, and comments on the event.    Fundraising and investment   Coming out of a global pandemic, in-person events initially added a degree… Read More

#Exclusive Content

#Funding #Molecular Genomics #Proteomics #Research study #Singapore #SomaLogic

Proteomics grant programme open to Singapore researchers

Proteomics company SomaLogic is sponsoring the Genomax Research Grant Award for researchers in Singapore, the company’s first grant in the APAC region. The winners of the award will receive proteomic data from SomaLogic’s 7,000-plex assay, which will be run at Singapore-based Molecular Genomics. The… Read More

#News

AI brain
#AI / data analytics / healthtech / informatics #Drug discovery #Funding #MultiOmic Health #Precision medicine #Seed funding #Start-ups

AI platform focuses on precision medicines for metabolic syndromes

AI drug discovery company MultiOmic Health has closed a £5 million ($6.2 million) seed funding extension round to build a precision therapeutics discovery platform for metabolic syndrome-related medical conditions. The round was led by London-based Hoxton Ventures, with participation from Ada Ventures, MMC Ventures and Verve… Read More

#News #Start-up Zone

Clinical research
#AACR #Cancer research #Funding #Johnson & Johnson #Lung cancer

AACR START Grant offers industry and academia experience

Postdoctoral and clinical fellows are invited to apply for the AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances through Research Training (START) Grant by June 21, 2023. This three-year, $225,000 grant will provide the opportunity for training and research in both academia and industry,… Read More

#News

#BioIndustry Association #Biotechnology #Clarivate #Funding #Investment #Private investment #UK

UK biotech sector raised £295 million in first quarter of 2023

The first quarter of 2023 has seen deal flow continue for UK life science and biotech companies at all stages of development, new data from the UK BioIndustry Association and Clarivate shows. As global macro-economic headwinds, suppressed public markets and political uncertainty weighed on investor confidence, venture investment remained steady,… Read More

#Business & Investment #Market Reports #News

#BioInnovation Institute #Drug discovery #Funding #Investment #Start-ups

Global start-ups: where is the innovation?

Listen to this article on the DDW Podcast: DDW takes a look at some key global activity taking place around the world for drug discovery and life sciences start-ups. UK Budget a ‘shot in the arm’ for oncology start-ups Before the UK announced its Spring Budget, UK BioIndustry Association (BIA) called… Read More

#Exclusive Content #Start-up Zone

Medical researcher
#Funding #Genetics / genomics #Investment #Paediatrics #Rare disease #SynaptixBio

‘Virtual’ biotech targets R&D funding on rare disease therapy

UK biotech firm SynaptixBio has secured £13.2 million to fund its development of the world’s first treatment for TUBB4A-related leukodystrophy, a rare, incurable and deadly disease. The company successfully raised £11.05m in its latest funding round to add to the £2.125m of seed funding from the last two years. It… Read More

#Business & Investment #News

Computer in laboratory
#Cancer research #Funding #Investment #Mosaic Therapeutics #Oncology #Wellcome Sanger Institute

Company raises $28m to develop targeted cancer therapies

Mosaic Therapeutics has closed its $28 million series A funding round and appointed former Novartis Oncology SVP Brian Gladsden as CEO. The Series A funding will be used to further advance Mosaic’s pipeline of targeted oncology therapies for biomarker-stratified populations, progressing its lead programmes through preclinical development to IND-enabling studies. Read More

#Business & Investment #Cancer Research #News #Start-up Zone

Seed fund
#Biologics / Biotechnology #Funding #Investment #SolasCure #Wound care

SolasCure secures £10.9m funding to develop Aurase Wound Gel

Biotechnology company SolasCure has completed its £10.9m ($13.3m) Series B investment round. The funding round was led by Seneca Partners and also included BRAIN Biotech, EVA Pharma, Jonathan Milner, and Wealth Club. SolasCure's first investigational product, Aurase Wound Gel, a hydrogel containing an enzyme cloned from medical maggots which aims… Read More

#Business & Investment #News